Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) EPS (Basic) (2024 - 2025)

RenovoRx (RNXT) has disclosed EPS (Basic) for 2 consecutive years, with -$0.08 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 33.33% to -$0.08 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.32 through Dec 2025, up 17.95% year-over-year, with the annual reading at -$0.32 for FY2025, 20.0% up from the prior year.
  • EPS (Basic) hit -$0.08 in Q4 2025 for RenovoRx, roughly flat from -$0.08 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.07 in Q1 2024 to a low of -$0.12 in Q4 2024.